Cargando…
Limited extent and consequences of pancreatic SARS-CoV-2 infection
Concerns that infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiological agent of coronavirus disease 2019 (COVID-19), may cause new-onset diabetes persist in an evolving research landscape, and precise risk assessment is hampered by, at times, conflicting evidence....
Autores principales: | van der Heide, Verena, Jangra, Sonia, Cohen, Phillip, Rathnasinghe, Raveen, Aslam, Sadaf, Aydillo, Teresa, Geanon, Daniel, Handler, Diana, Kelley, Geoffrey, Lee, Brian, Rahman, Adeeb, Dawson, Travis, Qi, Jingjing, D'Souza, Darwin, Kim-Schulze, Seunghee, Panzer, Julia K., Caicedo, Alejandro, Kusmartseva, Irina, Posgai, Amanda L., Atkinson, Mark A., Albrecht, Randy A., García-Sastre, Adolfo, Rosenberg, Brad R., Schotsaert, Michael, Homann, Dirk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s).
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858708/ https://www.ncbi.nlm.nih.gov/pubmed/35247306 http://dx.doi.org/10.1016/j.celrep.2022.110508 |
Ejemplares similares
-
The virucidal effects of 405 nm visible light on SARS-CoV-2 and influenza A virus
por: Rathnasinghe, Raveen, et al.
Publicado: (2021) -
SARS-CoV-2 spike E484K mutation reduces antibody neutralisation
por: Jangra, Sonia, et al.
Publicado: (2021) -
The E484K mutation in the SARS-CoV-2 spike protein reduces but does
not abolish neutralizing activity of human convalescent and post-vaccination
sera.
por: Jangra, Sonia, et al.
Publicado: (2021) -
Prophylactic protection against respiratory viruses conferred by a prototype live attenuated influenza virus vaccine.
por: Rathnasinghe, Raveen, et al.
Publicado: (2021) -
Interferon mediated prophylactic protection against respiratory viruses conferred by a prototype live attenuated influenza virus vaccine lacking non-structural protein 1
por: Rathnasinghe, Raveen, et al.
Publicado: (2021)